Additionally, B7-H4 is highly expressed in primary and metastatic serous, endometrioid, clear cell, and epithelial ovarian cancers, while its expression is lower in mucinous and non-epithelial ovarian cancers (37, 43–45). Here, VTCN1 is linked to ovarian carcinoma.